Day: December 13, 2022

Auriant Mining AB (publ.) announces 2023 production forecast

Written by Customer Service on December 13, 2022. Posted in Public Companies.

Auriant Mining AB (publ.) announces that its total production forecast for 2023 is 630-670 kg of gold. Ore to be fed to the Tardan CIL plant will come from Tardan’s ore zones and tailings of the Heap Leach. Annual throughput of the CIL plant will amount to 390 – 420 thousand tonnes. For more information, please contact: Danilo Lange, CEOTel: +7 495 109 02 82E-mail: d.lange@auriant.com Company name: Auriant Mining AB Short name: AURISIN-code: SE0001337213 Website: www.auriant.com Auriant Mining AB (AUR) is a Swedish junior mining company focused on gold exploration and production in Russia, primarily in the Republic of Tyva, Zabaikalye and the Republic of Khakassia. The company has currently four assets, including two operating mines (Tardan and Alluvial at Staroverinskaya), one early stage exploration asset and one development...

Vislink Unveils New Corporate Website Presence

Written by Customer Service on December 13, 2022. Posted in Public Companies.

Streamlined Design Reflects the Company’s Revised Branding and Features a More Simplified and User-Focused Site Experience Mt. Olive, NJ, Dec. 13, 2022 (GLOBE NEWSWIRE) — Vislink (Nasdaq: VISL), a global technology leader in the capture, delivery and management of high quality, live video and associated data in the media & entertainment, law enforcement and defense markets, is pleased to announce the launch of its new company website located at www.vislink.com. “We are excited to unveil our new corporate website presence to our customers, investors, affiliates and other visitors seeking information about the broad solutions that Vislink offers,” said Mickey Miller, CEO of Vislink. “In addition to providing a more simplified, user-focused experience, the website reflects the complete integration we have achieved with the products...

ILUS Completes Another Fire Safety Acquisition

Written by Customer Service on December 13, 2022. Posted in Mergers And Acquisitions.

NEW YORK, NY, Dec. 13, 2022 (GLOBE NEWSWIRE) — via NewMediaWire — ILUS International Inc. (OTC: ILUS) (Ilustrato Pictures International Inc.) is a Mergers and Acquisitions company focused on acquiring and growing public safety and industrial companies across the globe. The company has signed a Share Purchase Agreement to acquire 51% control of AL Shola Al Modea Safety and Security LLC (ASSS), an established and profitable fire safety company registered in the United Arab Emirates. In a strategic move by ILUS, the company has acquired the majority stake of ASSS to ramp up its Middle Eastern fire safety expansion plans. This involves ASSS working closely alongside BCD Fire, which was wholly acquired by ILUS in April 2021, to dominate the United Arab Emirates (UAE) fire safety sector through the leveraging of licensing, certifications,...

Vincerx Pharma Announces FDA Safe to Proceed Letter for Investigational New Drug (IND) Application for its αVβ3 Small Molecule-Drug Conjugate (SMDC) VIP236

Written by Customer Service on December 13, 2022. Posted in Public Companies.

VIP236 is a first-in-class αVβ3 integrin binder SMDC with the potential to address a broad patient population across multiple solid tumor indications Preclinical studies with VIP236 demonstrated promising tumor regression in in vivo cancer models VIP236 first-in-human study in advanced or metastatic solid tumors anticipated to commence in Q1 2023 PALO ALTO, Calif., Dec. 13, 2022 (GLOBE NEWSWIRE) — Vincerx Pharma, Inc. (Nasdaq: VINC), a biopharmaceutical company aspiring to address the unmet medical needs of patients with cancer through paradigm-shifting therapeutics, today announced that the U.S. Food and Drug Administration (FDA) has provided a safe to proceed letter and cleared the IND application for VIP236, the Company’s front-runner SMDC for the treatment of advanced solid tumors. VIP236 is a first-in-class SMDC with a tailored...

Brian Paras joins SeqLL as Chief Business Officer

Written by Customer Service on December 13, 2022. Posted in Public Companies.

BILLERICA, Mass., Dec. 13, 2022 (GLOBE NEWSWIRE) — SeqLL Inc. (“SeqLL” or the “Company”) (NASDAQ: SQL), a technology company providing life sciences instrumentation and research services, today announced that Brian Paras has joined the company as Chief Business Officer. “Brian brings 30-plus years of product introduction & commercialization, global sales & marketing leadership, and key industry partnership & strategic alliance building to the company. We excitedly welcome him aboard the SeqLL team, to lead commercial development and business operations as we move forward with groundbreaking True Single Molecule Sequencing (tSMS®) applications”, said Dan Jones, SeqLL CEO. “Brian also benefits from highly relevant single molecule technology experience that he will be leveraging in this role.” Prior to joining SeqLL,...

Beyond Cancer® Publishes Pre-Clinical Data in Cancer Cell International Demonstrating Its Tumor Ablation Method Utilizing Ultra-High Concentration Nitric Oxide (UNO) Induced a Systemic Response that Prevents Metastases

Written by Customer Service on December 13, 2022. Posted in Public Companies.

Data describe a potent systemic immune response resulting in a significant reduction in challenge tumors and improvement in survival for UNO treated miceChallenge Tumor Take Challenge tumor take was markedly reduced in UNO treated mice vs the naïve control groupTime Post Challenge Inoculation [Days] A significant survival advantage ( P < 0.001 ) was achieved in UNO treated mice compared to controlGARDEN CITY, N.Y. and HAMILTON, Bermuda, Dec. 13, 2022 (GLOBE NEWSWIRE) — Beyond Cancer, Ltd., an affiliate of Beyond Air, Inc. (NASDAQ: XAIR) that is focused on developing ultra-high concentration nitric oxide (UNO) for the treatment of solid tumors, announced today the publication of pre-clinical data demonstrating that its proprietary tumor ablation technology utilizing UNO results in a potent innate and adaptive immune response...

Rhyolite Resources Halts Development of Muckahi Mining System

Written by Customer Service on December 13, 2022. Posted in Public Companies.

TORONTO, Dec. 13, 2022 (GLOBE NEWSWIRE) — Rhyolite Resources Ltd. (TSXV: RYE) (“Rhyolite” or the “Company”) announces that the board of directors has elected to cease further development of the Muckahi Mining System due to the increasing uncertainty around securing and financing projects that adopt the System. Following the decision, the Company has released all employees previously retained in the further development of the System. This decision aims to preserve the cash of the Company and to focus on identifying new accretive options in order to serve the best interests of the shareholders. Further updates will be provided as they become available. Forward-Looking Statements This news release includes certain “forward-looking statements” under applicable Canadian securities legislation. Forward-looking statements include, but...

BrainsWay Reports Open Market Stock Purchase by Board Member Yossi Ben Shalom

Written by Customer Service on December 13, 2022. Posted in Public Companies.

BURLINGTON, Mass. and JERUSALEM, Dec. 13, 2022 (GLOBE NEWSWIRE) — BrainsWay Ltd. (NASDAQ & TASE: BWAY) (“BrainsWay” or the “Company”), a world leader in advanced and non-invasive treatment for brain disorders, today reported a recent open market purchase of BrainsWay American Depositary Receipts (ADRs) by Yossi Ben Shalom, an independent Director on the Company’s Board. Mr. Ben Shalom purchased 147,500 ADRs (representing 295,000 ordinary shares) on the open market for a total amount of $277,300, at an average price of $1.88 per ADR. “This investment reflects my strong belief in the value of BrainsWay, its technology, and its strategic vision,” stated Mr. Ben Shalom. “The Company’s impressive dossier of clinical evidence has shown that its unique, patented, and FDA-cleared Deep TMS™ platform is highly impactful in treating...

International Money Express to Present at the ICR Conference

Written by Customer Service on December 13, 2022. Posted in Public Companies.

MIAMI, Dec. 13, 2022 (GLOBE NEWSWIRE) — International Money Express (NASDAQ: IMXI), (“Intermex” or the “Company”) a leading money remittance services company, today announced the Company will present at the 25th Anniversary ICR Conference in Orlando, FL on Tuesday, January 10, 2023. The presentation will begin at 3:30 p.m. ET and will include comments from Andras Bende, chief financial officer. Investors and interested parties will be able to listen to the investor presentation via webcast at https://investors.intermexonline.com/news-events/events. The archived webcast will be available shortly after the conclusion of the presentation. About International Money Express, Inc.Founded in 1994, Intermex applies proprietary technology enabling consumers to send money from the United States and Canada to 18 countries in Latin America...

Citrine Global Corp. (CTGL) Signs MOU with MyPlant Bio, Specialized in Botanical Drug Development, to Acquire 55% of MyPlant’s Shares against Citrine Global Shares

Written by Customer Service on December 13, 2022. Posted in Public Companies.

Tel Aviv, Dec. 13, 2022 (GLOBE NEWSWIRE) — Citrine Global Corp. (OTCQB: CTGL) is pleased to announce the signing of a memorandum of understanding (MOU) with MyPlant Bio Ltd., a pioneering Israeli company that is specialized in botanical drug development and owns certain know-how and intellectual property rights that include a developed platform and cell-disease models to screen plant extracts to understand their biological effect, and has screening platforms using cell line models for certain diseases and conditions to detect effective plant materials and/or other substances for the treatment of these conditions. MyPlant was founded by Cannasoul Analytics, a leading botanical research and development company and Prof. Dedi Meiri from the Faculty of Biology at the Israeli Institute of Technology (Technion) and a member of the Technion...

Day: December 13, 2022

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Cookie Notice